MXPA01009690A - Moduladores de polisacaridos y usos de los mismos. - Google Patents

Moduladores de polisacaridos y usos de los mismos.

Info

Publication number
MXPA01009690A
MXPA01009690A MXPA01009690A MXPA01009690A MXPA01009690A MX PA01009690 A MXPA01009690 A MX PA01009690A MX PA01009690 A MXPA01009690 A MX PA01009690A MX PA01009690 A MXPA01009690 A MX PA01009690A MX PA01009690 A MXPA01009690 A MX PA01009690A
Authority
MX
Mexico
Prior art keywords
glycosaminoglycan
peptides
sulfate
chitosan
mediated processes
Prior art date
Application number
MXPA01009690A
Other languages
English (en)
Inventor
Akira Takashima
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of MXPA01009690A publication Critical patent/MXPA01009690A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion proporciona peptidos con una afinidad especifica para moleculas de gIicosaminogIicanos. Estos peptidos pueden tener cualquier numero de funciones, incluyendo, pero no limitado al uso como inhibidores de procesos mediatizados con glicosaminoglicanos, aumentadores de procesos mediatizados con glicosaminoglicanos, y como sondas moleculares para identificar la presencia de un glicosaminoglicano especifico. Los peptidos de la invencion pueden ser dirigidos contra cualquier glicosaminoglicano, incluyendo acido hialuronico, sulfato A de condroitina, sulfato C de condroitina, sulfato de dermatan, heparina, sulfato de ceratan, ceratosulfato, quitin, quitosan 1, y quitosan 2. Estos peptidos aislados pueden tener usos terapeuticos en el tratamiento o prevencion de enfermedades que involucran infeccion, enfermedades inflamatorias, cancer, infecciones, etc. Los peptidos pueden tener tambien otras funciones biologicas tales como anticoncepcion.
MXPA01009690A 1999-03-26 2000-03-22 Moduladores de polisacaridos y usos de los mismos. MXPA01009690A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12647599P 1999-03-26 1999-03-26
PCT/US2000/007813 WO2000057896A1 (en) 1999-03-26 2000-03-22 Modulators of polysaccharides and uses thereof

Publications (1)

Publication Number Publication Date
MXPA01009690A true MXPA01009690A (es) 2003-06-24

Family

ID=22425031

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01009690A MXPA01009690A (es) 1999-03-26 2000-03-22 Moduladores de polisacaridos y usos de los mismos.

Country Status (13)

Country Link
US (2) US6653285B1 (es)
EP (1) EP1165112B1 (es)
JP (1) JP2002540161A (es)
AT (1) ATE328603T1 (es)
AU (1) AU774650B2 (es)
CA (1) CA2366604A1 (es)
CY (1) CY1105531T1 (es)
DE (1) DE60028558T2 (es)
DK (1) DK1165112T3 (es)
ES (1) ES2265928T3 (es)
MX (1) MXPA01009690A (es)
PT (1) PT1165112E (es)
WO (1) WO2000057896A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002076173A2 (en) * 2001-03-21 2002-10-03 The University Of Texas System Inhibitors of glycosaminoglycans
WO2003040368A2 (en) * 2001-11-09 2003-05-15 Transition Therapeutics Inc. Pharmaceutical compositions of marine sponge microciona prolifera
ITPD20020003A1 (it) 2002-01-11 2003-07-11 Fidia Advanced Biopolymers Srl Biomateriali a base di acido ialuronico come terapia anti-angiogenicanella cura dei tumori.
US20060198800A1 (en) * 2003-08-14 2006-09-07 Natalie Dilallo Skin care compositions including hexapeptide complexes and methods of their manufacture
WO2005016364A1 (en) * 2003-08-14 2005-02-24 Guthy-Renker Corporation Skin care composition including hexapeptide complexes and methods of their manufacture
KR101678925B1 (ko) 2008-06-30 2016-11-24 에스바테크 - 어 노바티스 컴파니 엘엘씨 기능화 폴리펩티드
EP2307440A4 (en) * 2008-07-01 2012-12-19 Zacharon Pharmaceuticals Inc HEPARAN SULFATE INHIBITORS
US8592140B2 (en) 2009-01-02 2013-11-26 Biomarin Pharmaceutical Inc. Detection of oligosaccharides
US9029530B2 (en) * 2009-01-02 2015-05-12 Biomarin Pharmaceutical Inc. Detection of oligosaccharides
US8232073B2 (en) 2009-01-02 2012-07-31 Zacharon Pharmaceuticals, Inc. Quantification of non-reducing end glycan residual compounds
US8809009B2 (en) 2009-01-02 2014-08-19 Biomarin Pharmaceutical Inc. Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker
US20130071408A1 (en) * 2010-02-01 2013-03-21 Atul J. Butte Methods for Diagnosis and Treatment of Non-Insulin Dependent Diabetes Mellitus
EP3249662B1 (de) * 2016-05-27 2020-05-13 Hanning Elektro-Werke GmbH & Co. KG Elektrischer pumpenmotor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9207949D0 (en) 1992-04-09 1992-05-27 Univ Manitoba Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility
US5981478A (en) * 1993-11-24 1999-11-09 La Jolla Cancer Research Foundation Integrin-binding peptides
CA2237051A1 (en) 1997-12-19 1999-06-19 Eva A. Turley Enhanced affinity hyaluronan binding peptides
EP1324765A1 (en) * 2000-10-05 2003-07-09 Transition Therapeutics Inc. Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans

Also Published As

Publication number Publication date
US6923965B2 (en) 2005-08-02
JP2002540161A (ja) 2002-11-26
ATE328603T1 (de) 2006-06-15
ES2265928T3 (es) 2007-03-01
DE60028558D1 (de) 2006-07-20
DK1165112T3 (da) 2006-10-09
WO2000057896A1 (en) 2000-10-05
EP1165112B1 (en) 2006-06-07
EP1165112A4 (en) 2002-09-25
US6653285B1 (en) 2003-11-25
EP1165112A1 (en) 2002-01-02
US20040138105A1 (en) 2004-07-15
AU4025500A (en) 2000-10-16
PT1165112E (pt) 2006-10-31
AU774650B2 (en) 2004-07-01
CY1105531T1 (el) 2010-07-28
CA2366604A1 (en) 2000-10-05
DE60028558T2 (de) 2007-05-16

Similar Documents

Publication Publication Date Title
CY1105531T1 (el) Ρυθμιστες πολυσακχαριδιων και χρησεις αυτων
NZ333925A (en) Use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus
EP2085780A3 (en) Methods and products related to low molecular weight heparin
ATE273324T1 (de) Heparinähnliche sulfatierte polysaccharide
NZ263057A (en) Use of bactericidal permeability increasing proteins or derivative for treating chronic inflammatory diseases, neutralising heparin, inhibiting angiogenesis, tumour and epithelial cell proliferation
WO2007070547A3 (en) Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
PE20001112A1 (es) Derivados de quinolina como agentes antibacterianos
CA2354832A1 (en) Chlorella preparations exhibiting immunomodulating properties
BR0313239A (pt) Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de doenças
CA2414320A1 (en) Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections
BR9508323A (pt) Uso de quitosan e um polissacarídeo imobilizado no mesmo escolhido dentre heparina sulfato de herpan e sulfato de extran e processo para impedir ou reduzir substancialmente a adesão indesejável de tecidos com relação à cicatrização de feridas
DE60219653D1 (de) Pharmazeutische zusammensetzung mit chito-oligomeren
DE69316758D1 (de) Selbstvernetztes gellangummi
WO2000058475A3 (en) Streptococcus pneumoniae antigens
CA2472093A1 (en) Use of sulfated glycosaminoglycans for establishing effective labor in women
WO2002076173A3 (en) Inhibitors of glycosaminoglycans
DE60305169D1 (de) Therapeutische zubereitungen enthaltend modifizierte polysaccharide
TR200001682T2 (tr) Değiştirilmiş biyolojik tanınma gösteren değiştirilmiş polisakaridler
EP0361490A3 (en) Sulfated oligosaccharides and derivatives thereof
NO20012849D0 (no) Ny terapeutisk anvendelse for hepariner med lav molekylvekt
BR9809504A (pt) Utilização de uma heparina de baixo peso molecular
IL148336A0 (en) Medicaments that contain xenogenic oligo-or/and polyribonucleotides
TW200740733A (en) Small molecule glycosaminoglycan mimetics
UA29489C2 (uk) Композиція, що має бактерицидні та ранозагоюючі властивості
BR9806540A (pt) Composição farmacêutica para tratamento de hemofilia ou bronquite asmática

Legal Events

Date Code Title Description
FG Grant or registration